(Pharm Res[TA])
10,381 results
  • Identity Testing of Biopharmaceuticals using Nano-Differential-Scanning-Fluorimetry. [Journal Article]
    Pharm Res. 2026 Oct 27. [Online ahead of print]Fakler E, Kiessig S, … Allmendinger APR
  • CONCLUSIONS: The nanoDSF method's robustness and rapid turnaround time support its suitability as an ID test for facilities handling multiple products and diverse product types. The selected data analysis approach does not require generation of statistical models enabling simplified method validation and implementation in QC.
  • Formulation Development and Characterization of Ibrutinib-Loaded Liposomes with Molecular Dynamics Insights. [Journal Article]
    Pharm Res. 2026 Oct 26. [Online ahead of print]Cheng X, John R, … Gupta PPR
  • CONCLUSIONS: The combined computational and experimental approach provided complementary molecular-level insights into liposome formulation behavior. Although the simulations did not predict quantitative outcomes, they offered mechanistic context that supported empirical findings. This approach demonstrated the potential utility of integrating MD simulations with experimental studies during early-stage formulation development.